Skip to content

Study · Animal study (in vivo) · rabbit · 1985

6 results

Electroencephalographic and autonomic effects of centrally administered dermorphin in rabbits.

Tartara A, Maurelli M, Marchioni E

Peptides1 Jan 1985Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In conscious rabbits, dermorphin increased the cortical total power density spectrum.

    In plain wordsIn rabbits, dermorphin increased the total power density spectrum of the cortex.

    Peptide
    Dermorphin
    Outcome
    IncreaseCortical total power density spectrum
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In conscious rabbits, dermorphin decreased hippocampal total power.

    In plain wordsIn rabbits, dermorphin decreased the total power of the hippocampus.

    Peptide
    Dermorphin
    Outcome
    DecreaseHippocampal total power
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.
  3. 03AnimalAnimal study (in vivo)Safety outcome

    In rabbits, dermorphin caused respiratory depression.

    In plain wordsIn rabbits, dermorphin caused respiratory depression.

    Peptide
    Dermorphin
    Outcome
    IncreaseRespiratory depression
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Adverse events · Respiratory
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    Simultaneously the peptide causes respiratory depression, bradycardia and hypothermia.
    1 context sentence
    Summary · context
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.
  4. 04AnimalAnimal study (in vivo)Safety outcome

    In rabbits, dermorphin caused bradycardia.

    In plain wordsIn rabbits, dermorphin caused a slow heart rate.

    Peptide
    Dermorphin
    Outcome
    IncreaseBradycardia
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Adverse events · Cardiovascular
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    Simultaneously the peptide causes respiratory depression, bradycardia and hypothermia.
    1 context sentence
    Summary · context
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.
  5. 05AnimalAnimal study (in vivo)Safety outcome

    In rabbits, dermorphin caused hypothermia.

    In plain wordsIn rabbits, dermorphin caused low body temperature.

    Peptide
    Dermorphin
    Outcome
    IncreaseHypothermia
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    Simultaneously the peptide causes respiratory depression, bradycardia and hypothermia.
    1 context sentence
    Summary · context
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.
  6. 06AnimalAnimal study (in vivo)Mechanism

    In rabbits, the dermorphin electrocortical pattern resembled that reported for other opiates and mu agonists.

    In plain wordsIn rabbits, dermorphin produced a brain electrical pattern similar to other opiates.

    Peptide
    Dermorphin
    Outcome
    Not applicableElectrocortical pattern
    Study

    rabbitsn: not reported in source

    conscious rabbits
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated · third ventricleAs given in this study (rabbits).

    Source sentences

    Summary
    The electrocortical pattern is similar to that found with other opiates and reported as specific of mu agonists.
    1 context sentence
    Summary · context
    Dermorphin, administered into the third ventricle of conscious rabbits, induces an increase of the total power density spectrum of the cortex and a decrease of the total power of the hippocampus.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.